Your search for ‘Smart & Biggar’ returned 2,495 results

Earlier this year we reported on a decision of the Federal Court of Appeal in which the University of Alberta sought to revive an abandoned patent application after the reinstatement period had expired.

Join us as we celebrate International Women's Day with our new podcast led by three lawyers looking back on their road to success. Hear from Bereskin & Parr's Intellectual...

oin us as we support Neurodiversity Celebration Week. In this podcast, partner Micheline Gravelle chats with partner Bhupinder Randhawa about his views and experiences in working with ADHD in a law firm environment.

New Court Proceedings.

In a recent decision, the National Advertising Division took a stance against using lash inserts in mascara advertising making specific performance claims.

On June 15, 2018, Health Canada announced the publication of proposed Regulations Amending the Food and Drug Regulations and the Regulations Amending the Medical Devices Regulations.

The Supreme Court of Canada has today granted AstraZeneca leave to appeal a Federal Court of Appeal decision, affirming a trial decision invalidating its patent relating to its successful esomeprazole drug (NEXIUM) for lack of utility.

Following pre-publication on July 15, and flowing from its commitments under CETA, the Certificates of Supplementary Protection Regulations and the Regulations Amending the Patented Medicines...

A draft of the new Guidelines is expected in the spring of 2018.

On September 20, 2013, the International Trademark Association ("INTA"), a not-for-profit association of more than 5,900 members consisting of trade-mark owners, trade-mark professionals and academics from more than 190 countries, was granted leave by the Quebec Superior Court to intervene in a declaratory judgment proceeding pertaining to the interplay between the Quebec’s Charter of the French language (the "French Charter") and trade-marks.

In 2018 we reported on a number of developments in life sciences IP and regulatory law. Our most-read articles were: #1 a June update on biosimilars (authored by Urszula Wojtyra);

The Federal Court of Appeal upheld a decision finding Nova Chemicals Corporation liable for infringement of a patent owned by The Dow Chemical Company by Nova's manufacture and sale of its SURPASS film-grade polymers.

On April 24, 2019, the Federal Court of Appeal (FCA) affirmed the Federal Court's (FC) dismissal of Apotex's application for judicial review of a decision

The Generic Submissions Under Review (GSUR) list (previously reported) is a list of Abbreviated New Drug Submissions (generic submissions) ...

On June 15, 2019, the Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Post-market Surveillance of Medical Devices) (Regulations) were pre-published

On March 13, 2019, the Competition Bureau ("Bureau") published the final version of its updated Intellectual Property Enforcement Guidelines (IPEGs).

On November 21, 2022, the Minister of Health tabled the 2021 Annual Report of the Patented Medicine Prices Review Board.